News | April 25, 2013

Toshiba Partners With Leading Universities for Advanced MR Research

Introduces new sequence development environment at ISMRM

April 25, 2013 — Leading research institutions are making breakthroughs in advanced magnetic resonance (MR) imaging with Toshiba America Medical Systems Inc.’s Vantage Titan 3.0T MR system. Toshiba has partnered with Shands at the University of Florida and the Keck Medical Center of the University of Southern California (USC) for MR clinical research in functional MRI (fMRI), as well as body and cardiac imaging.

 “We’re utilizing the Titan 3.0T MR to enhance visualization of cerebral spinal fluid (CSF) flow non-invasively and in the research of traumatic brain injuries from combat and athletics,” said Anthony Mancuso, professor and chairman of the department of radiology, UF College of Medicine. “The Titan 3.0T fulfills all the promises of a high-end 3.0T system, with high image quality, gradient homogeneity and patient-focused features.”

As part of Toshiba’s commitment to supporting institutions in advanced MR research, Toshiba is demonstrating the new sequence development environment (NSDE), a research-only tool that allows the research community to develop its own pulse sequences to explore new applications of MR imaging.

“Partnering with prestigious universities such as USC and Shands at the University of Florida illustrates our commitment to developing advanced technology that can expand the potential clinical applications of MR imaging,” said Suresh Narayan, senior manager, market development, MR business unit, Toshiba.

Toshiba showcased the Titan 3.0T with NSDE at this year’s International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting in Salt Lake City, April 20-26, 2013.

For more information: www.medical.toshiba.com

Related Content

Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Clinical Study | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Clinical Study | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Clinical Study | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Clinical Study | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Clinical Study | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init